Ignite Creation Date:
2024-05-05 @ 4:36 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00275496
Status:
COMPLETED
Last Update Posted:
2015-09-02
First Post:
2006-01-10
Brief Title:
Multicenter Selective Lymphadenectomy Trial MSLT
Sponsor:
Saint Johns Cancer Institute
Organization:
Saint Johns Cancer Institute
Study Overview
Official Title:
A Clinical Study of Wide Excision Alone Versus Wide Excision With Intraoperative Lymphatic Mapping and Selective Lymph Node Dissection in the Treatment of Patients With Cutaneous Invasive Melanoma
Status:
COMPLETED
Status Verified Date:
2014-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Subjects must be diagnosed with melanoma All subjects receive Wide Excision WEX of their melanoma If the melanoma meets study requirements the subject is randomized to receive either 1 no further surgical procedures as part of the study or 2 a Selective Lymphadenectomy with the possibility of a Complete Lymphadenectomy Subjects are then followed for 10 years
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NIH P01 CA029605 | None | None | None |